CymaBay Therapeutics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (38)

Latest Posts

About This Stock More About This Stock
Street Missing 'Eye-Catching' CymaBay Data, Says Piper Sandler
Article By: The Fly
Monday, August 3, 2020 1:36 PM EDT
August 3's topline data from CymaBay's halted Phase 3 study answered key questions for seladelpar around its effect on itch, a hallmark symptom of primary biliary cholangitis, Piper Sandler analyst Yasmeen Rahimi tells investors in a research note.
In this article: CBAY
Read
'Underwhelming' Intercept Data Hurts CymaBay Bear Thesis, Says Piper Jaffray
Article By: The Fly
Wednesday, February 20, 2019 5:48 AM EDT
A major constituent of the CymaBay bear thesis has now been removed.
In this article: CBAY Also: ICPT
Read
Why Are Top Analysts Obsessed With These 3 Disruptive Stocks?
Article By: TipRanks
Sunday, December 3, 2017 12:53 PM EDT
Here we focus in on three stocks that have the power to disrupt- and have significant backing from the Street. All these stocks have a ‘Strong Buy’ rating from the best-performing analysts- and big upside potential from the current share price.
In this article: AMZN, CBAY, SEDG
Read
CymaBay Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, July 19, 2017 1:19 PM EDT
CymaBay Therapeutics, Inc., today announced the pricing of its previously announced underwritten public offering of 13,000,000 shares of its common stock at a public offering price of $6.50 per share.
In this article: CBAY
Read
5 Breakout Stocks For Superior Returns
Article By: Swarup Gupta
Friday, February 10, 2017 10:50 AM EDT
Utilizing a breakout investment strategy is a favored choice of active investors who are content only with returns superior to most other investments.
In this article: GNK, CBAY, CMRX, SMMT, MODN
Read

PARTNER HEADLINES

Latest Tweets for $CBAY

No tweets yet!